Robin J. Blagg
Research Subjects
Research Interests
Robin J. Blagg has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Benita Percival
Medical Technologies Innovation Facility (MTIF), Clifton Lane, Nottingham Trent University, Nottingham NG11 8NS, UK
1 shared publication - Elena Hunter
Medical Technologies Innovation Facility (MTIF), Clifton Lane, Nottingham Trent University, Nottingham NG11 8NS, UK
1 shared publication - Emily Blackwell
Bristol Veterinary School, University of Bristol, Langford, UK
1 shared publication - James Sagar
Oxford Instruments Magnetic Resonance, Abingdon, UK
1 shared publication - John Alan Hunt
Medical Technologies Innovation Facility, Nottingham Trent University, Nottingham, UK
1 shared publication - Luisa De Risio
Nottingham Trent University, Southwell, UK
1 shared publication
Latest Publications
- Open Access
- 24 December 2021
- Published by Springer Nature in BMC Research Notes
- Vol. 14 (1) , 1-5
Preliminary demonstration of benchtop NMR metabolic profiling of feline urine: chronic kidney disease as a case study
Objective: The use of benchtop metabolic profiling technology based on nuclear magnetic resonance (NMR) was evaluated in a small cohort of cats with a view to applying this as a viable and rapid metabolic tool to support clinical decision making. Results: Urinary metabolites were analysed from four subjects consisting of two healthy controls and two chronic kidney disease (CKD) IRIS stage 2 cases. The study identified 15 metabolites in cats with CKD that were different from the controls. Among them were acetate, creatinine, citrate, taurine, glycine, serine and threonine. Benchtop NMR technology is capable of distinguishing between chronic kidney disease case and control samples in a pilot feline cohort based on metabolic profile. We offer perspectives on the further development of this pilot work and the potential of the technology, when combined with sample databases and computational intelligence techniques to offer a clinical decision support tool not only for cases of renal disease but other metabolic conditions in the future.
- 24 December 2021
- Published by Springer Nature in BMC Research Notes
- Vol. 14 (1) , 1-5
Open AccessPreliminary demonstration of benchtop NMR metabolic profiling of feline urine: chronic kidney disease as a case study
Objective: The use of benchtop metabolic profiling technology based on nuclear magnetic resonance (NMR) was evaluated in a small cohort of cats with a view to applying this as a viable and rapid metabolic tool to support clinical decision making. Results: Urinary metabolites were analysed from four subjects consisting of two healthy controls and two chronic kidney disease (CKD) IRIS stage 2 cases. The study identified 15 metabolites in cats with CKD that were different from the controls. Among them were acetate, creatinine, citrate, taurine, glycine, serine and threonine. Benchtop NMR technology is capable of distinguishing between chronic kidney disease case and control samples in a pilot feline cohort based on metabolic profile. We offer perspectives on the further development of this pilot work and the potential of the technology, when combined with sample databases and computational intelligence techniques to offer a clinical decision support tool not only for cases of renal disease but other metabolic conditions in the future.